A capture step with protein A is the most common purification step in the downstream purification process of monoclonal antibodies. It is therefore of great importance to increase the knowledge of the interactions involved in this purification technique. The purpose of this master thesis project was to determine the affinity of protein A domains to IgG subclasses by surface plasmon resonance (SPR). Besides the five homologous IgG-binding protein A domains (E, D, A, B, and C) an engineered domain, similar to domain B and used in the protein A media MabSelect Sure™ (GE Healthcare) was included in the study. The domains were expressed in E.coli, affinity purified and immobilized onto sensor chip surfaces by amine coupling. The antibodies used in the interaction analyses were of the human IgG subclasses 1, 2, 3, and 4. Affinity determination was performed by kinetic analyses with the SPR-biosensor Biacore™ 2000. All human IgG subclasses except IgG3 were shown to bind to all protein A domains including the monomer of the SuRe ligand. The equilibrium constants, KD-values, obtained were all in the low nanomolar range. For IgG1 and IgG4, no significantly differences in the affinity to any of the protein A domains were found, except for domain E where there might be quality issues of the prepared domain. Furthermore, a detected quality issue with the commercial IgG2 made it impossible to determine the KD-values for this subclass with any reliability.

abstract: Biosensors aiming at detection of target analytes, such as proteins, microbes, virus, and toxins, are widely needed for various applications including detection of chemical and biological warfare (CBW) agents, biomedicine, environmental monitoring, and drug screening. Surface Plasmon Resonance (SPR), as a surface-sensitive analytical tool, can very sensitively respond to minute changes of refractive index occurring adjacent to a metal film, offering detection limits up to a few ppt (pg/mL). Through SPR, the process of protein adsorption may be monitored in real-time, and transduced into an SPR angle shift. This unique technique bypasses the time-consuming, labor-intensive labeling processes, such as radioisotope and fluorescence labeling. More importantly, the method avoids the modification of the biomarker’s characteristics and behaviors by labeling that often occurs in traditional biosensors. While many transducers, including SPR, offer high sensitivity, selectivity is determined by the bio-receptors. In traditional biosensors, the selectivity is provided by bio-receptors possessing highly specific binding affinity to capture target analytes, yet their use in biosensors are often limited by their relatively-weak binding affinity with analyte, non-specific adsorption, need for optimization conditions, low reproducibility, and difficulties integrating onto the surface of transducers. In order to circumvent the use of bio-receptors, the competitive adsorption of proteins, termed the Vroman effect, is utilized in this work. The Vroman effect was first reported by Vroman and Adams in 1969. The competitive adsorption targeted here occurs among different proteins competing to adsorb to a surface, when more than one type of protein is present. When lower-affinity proteins are adsorbed on the surface first, they can be displaced by higher-affinity proteins arriving at the surface at a later point in time. Moreover, only low-affinity proteins can be displaced by high-affinity proteins, typically possessing higher molecular weight, yet the reverse sequence does not occur. The SPR biosensor based on competitive adsorption is successfully demonstrated to detect fibrinogen and thyroglobulin (Tg) in undiluted human serum and copper ions in drinking water through the denatured albumin. / Dissertation/Thesis / Doctoral Dissertation Electrical Engineering 2015

No description available.

No description available.

No description available.

Coagulation factor XI plays an important role in the consolidation phase of blood coagulation. Previous studies from our laboratory and others have demonstrated that zymogen factor XI (FXI) binds to heparin with moderate (KD~110 nM) affinity via residues (K252, K253 and K255) located in the apple 3 (A3) domain of the molecule. In contrast, the enzyme, factor XIa (FXIa), was shown to bind to heparin with significantly higher affinity (~1.5 nM by ELISA) via residues (K529, R530 and R532) within the catalytic domain (CD). The interaction between heparin and FXIa potentiates the inhibition of FXIa by protease nexin-2 by 10-fold. In addition, related polyanions heparin and dextran sulfate inhibit the catalytic activity of FXIa. The present study was designed to determine the relative contributions of positively charged residues as well as the dimeric structure of FXI in heparin binding. During this project, wtFXI, FXIR504A, FXIK505A, FXIR507A, FXIR529A, FXIR530A, FXIR532A, and FXIR586A have been expressed and purified. All mutants were homogenous and identical to wtFXI on SDS-PAGE, clotting assays and 1G5 monoclonal antibody binding studied by SPR. In addition, monomeric FXI C321S/K331A was expressed and purified. Utilizing an ELISA assay, no difference in the affinity for heparin between FXIa and FXI was found. Surface plasmon resonance (SPR) data collected for FXI clearly indicate a complex interaction which does not conform to a simple 1:1 Langmuir binding model making it difficult to obtain quantitative information. The complexity of FXI interactions with heparin is likely to arise from the multivalent nature of the binding, in which both protein and heparin have multiple binding sites. Two positively charged residues in the FXI catalytic domain, FXIR507A and FXIR532A, were found to be particularly important for interaction with heparin. The FXIR507A and FXIR532A mutants demonstrated ~ 65% and ~50% decreases respectively in total number of heparin binding sites based on ELISA. Also, the apparent dissociation constants for FXIR507A (KDapp ~13 nM) and FXIR532A (KDapp ~21 nM ) were 6 and 10-fold increased respectively compared with 2.1 nM for the wtFXI. Mutant FXIR586A also demonstrated a defect in affinity (KDapp ~ 13 nM) without an effect on the Bmax. The monomeric FXIC321S/R331A was also characterized for its ability to bind heparin compared with wtFXI. Surprisingly, the monomeric FXI displayed defective binding to heparin according to ELISA (KDapp ~ 30 nM) and SPR methods. Thus, the unique homodimeric structure of FXI in addition to the residues both in its catalytic and A3 domain chains are necessary for high-affinity heparin binding. / Biochemistry

Surface plasmon resonance (SPR) is a label-free, versatile and highly sensitive method for studying molecular interactions in real time. It is widely used by industry and academia alike in fields ranging from Alzheimer’s disease research to detection of heavy metals. In this review, studies published during the last 10 years using Biacore or other SPR instruments were compiled and compared. Trends were also identified in the field. Amine coupling was found to be the most common ligand strategy for proteins, and most SPR research related to the field of medicine. Furthermore, three main purposes of an SPR experiment were identified: To determine the affinity between a pair of molecules, kinetics between a pair of molecules or to detect a certain molecule in a solution. The results presented are often related to these three purposes, and are most often presented and evaluated in terms of kinetic, affinity and sensitivity constants. SPR can be used for studying a broad range of molecular interactions, and an overview was obtained by dividing up the field into different parts based on molecular interactions and SPR methods. The study of molecular interactions using SPR was divided into protein-protein interactions (PPIs), antibody-antigen, protein-biomolecule interactions, interactions between proteins and small molecules, and non-conventional SPR methods. Non-conventional SPR methods include localized surface plasmon resonance (LSPR) and SPR imaging (SPRi), which are both based on the same optical sensing principles as SPR.

Cellulose and hemicelluloses have attracted increasing interest as renewable biopolymers because of their abundance. Furthermore, the recognition of biomass as a sustainable and renewable source of biofuels has driven research into the assembly and disassembly of polymers within plant cell walls. Cellulose thin films are useful in the study of interactions between cellulose and hemicelluloses, and quartz crystal microbalances with dissipation monitoring (QCM-D), surface plasmon resonance (SPR) and atomic force microscopy (AFM) are widely used to investigate polymer adsorption/desorption at liquid/solid interfaces. In this study, smooth trimethylsilyl cellulose (TMSC) films were spincoated onto gold QCM-D sensors and hydrolyzed into ultrathin cellulose films upon exposure to aqueous HCl vapor. The adsorption of arabinoglucuronoxylan (AGX) and arabinoxylan (AX) onto these cellulose surfaces was studied. The effects of structure, molar mass and ionic strength of the solution were considered. Increasing ionic strength increased AGX and AX adsorption onto cellulose. While AGX showed greater adsorption onto cellulose than AX by QCM-D, the trend was reversed in SPR experiments. The combination of QCM-D and SPR data showed a greater amount of water was trapped within the AX films. Both adsorbed AGX and AX films were subsequently visualized by AFM. Images from AFM showed AGX and AX adsorbed as aggregates from water, while AGX and AX adsorbed from CaCl2 yielded smaller xylan particles with more numerous globular structures on the cellulose surfaces. Images from AFM of xylan films on bare gold surfaces also showed layers of uniform aggregates that were consistent with AX and AGX aggregation in solution. / Master of Science

Les aptamères correspondent à de courtes séquences d'oligonucléotides possédant une forte affinité et spécificité envers un ligand (petites molécules organiques, peptides, acides nucléiques, protéines, cellules). Du fait de leurs remarquables propriétés, ils sont utilisés comme alternative aux anticorps dans les dispositifs de type biocapteur/biopuce, notamment pour la détection de petites molécules (PM < 2000 Da). L'imagerie de résonance des plasmons de surface (SPRi) est une technique de détection optique qui a gagné une attention croissante ces dernières années. Elle est basée sur un principe de variation de l'indice de réfraction d'une surface sélective lors de l'interaction sonde/cible. Sa sensibilité est néanmoins limitée aux molécules de poids moléculaire supérieur à 2000 Da. Dans le cadre de ces travaux, nous avons développé une biopuce à aptamères pour à la détection d'une petite molécule, l'adénosine, au moyen de la technique de résonance des plasmons de surface (SPR). Pour cela, deux différentes stratégies ont été développées. La première combine l'utilisation de nanoparticules d'or (AuNPs) pour l'amplification du signal SPRi avec l'ingénierie des séquences d'aptamères. La seconde stratégie est basée sur l'exploitation de la stabilité thermodynamique apportée par l'interaction de la cible (adénosine) avec les séquences d'aptamères. Le dispositif SPR est alors couplé à un système de régulation de température, permettant ainsi d'assurer la dissociation des complexes et d'établir des profils de dénaturation caractéristiques. Nos résultats initient ainsi une nouvelle approche dans la détection de petites molécules par SPRi et ouvrent de nouvelles perspectives de développement des biocapteurs à aptamères. / Aptamers are single-stranded DNA (ssDNA) or RNA molecules capable of binding to target molecules, including proteins, metal ions and drugs. Because of their specific binding abilities and many advantages over antibodies (higher stability, lower cost, easy chemical modification…), they provide a great opportunity to produce sensing surfaces for effective and selective detection of small molecules. Surface Plasmon Resonance imaging (SPRi) has become one of the most widely used label-free method for the study of biorecognition events on sensor surfaces. This technique provides a rapid approach, however, limited by low refractive index changes occurring when small molecules (<2000 Da) are captured on the sensor. Whereas significant reflectivity variation is observed upon the interaction of large molecules like proteins with the sensing interface, for small molecules targets such adenosine, the reflectivity variation is often too small to be detected by SPRi. Thereby, only few studies have been reported so far on SPRi-based biosensor for small molecules detection using aptamers. In this work, we developed two bioassay strategies for the detection of a model small molecule, adenosine, using Surface Plasmon Resonance imaging. The first one combines the SPRi signal enhancement effect induced by gold nanoparticles (AuNPs) with the advantage of using engineered DNA aptamers. The experimental results have demonstrated that the presence of gold nanoparticles and adenosine, which works as a molecular linker between engineered aptamer fragments, can significantly increase the SPRi response. The second strategy is based on the thermodynamics of binding between adenosine and its aptamer. To that end, SPRi technique was coupled with rigorous temperature control and aptamer duplex stability was monitored (affected by target binding) by quantification of melting transitions. Our results initiate a new approach for small molecule detection using SPRi with the aim to validate future prospects for integration in parallelized platform.

Les RCPG sont exprimés dans tous types de tissus et sont impliqués dans la régulation de nombreux processus biologiques et ont pour rôle de capter un vaste panel de stimuli extracellulaires qu’ils transmettent à l’intérieur de la cellule. Récemment, le laboratoire a identifié une nouvelle famille de dix protéines, les GASP, qui interagissent avec les RCPG et moduleraient leur trafic intracellulaire. Alors que GASP-1 est le membre de cette famille le mieux caractérisé et que son interaction avec de nombreux RCPG soit documentée, peu d’informations sont disponibles sur les modalités d’interaction de cette protéineavec les RCPG au niveau moléculaire. La première partie de ce projet de thèse a consisté à étudier les modalités d’interaction entre les GASPs et les RCPG au niveau moléculaire. Nous avons ainsi pu montrer à l’aide de techniques biochimiques et biophysiques, l’importance d’un motif répété et conservé de 15 acides aminés pour l’interaction de GASP-1 avec divers RCPG. Par la suite, les résultats obtenus ont été exploités pour mettre en place un essai de criblage qui nous a permis d’identifier des petites molécules capables de perturber l’interaction entre GASP-1 et le récepteur beta-2 adrénergique. Enfin, l’absence de données structurales sur les protéines de la famille GASP nous a ensuite poussé à la réalisation d’études structurales de ces protéines à la fois par cristallographie et par RMN. Bien que les résultats obtenus ne nous aient pas encore permis d’obtenir la structure de ces protéines, des expériences préliminaires de RMN ont permis deconfirmer l’implication des acides aminés tryptophanes présents au sein des motifs GASP dans l’interaction avec les RCPG. / GPCRs represent one of the most diversified protein families in humans. They translate extracellular stimuli into intracellular signals to modulate a large panel of physiological processes making them unrivalled targets for development of new therapeutic agents. Recently, we identified the GASP family of proteins that interact with GPCRs and modulate the postendocyticfate of agonist activated receptors. GASP-1 is the well-characterized protein of this family and has been shown to be involved in the sorting of receptors that are quickly degraded following agonistpromoted internalization. Although GASP-1 was found to interact with numerous GPCR both in vitro and in vivo and that helix 8 of GPCRs is critically involved in this interaction, little is known about which region within GASP-1 is required for its interaction with GPCRs. In this work, we first present a detailed analysis of the molecular interaction between GASPs and GPCRs. By using biochemical and biophysical experiments we shown that the central domain of GASP-1 is critical for the interaction with GPCRs and that a conserved and repeated sequence of 15 amino acids plays a critical role in this interaction. In a second step, we developed an HTC assay allowing us to identify small molecules able to disrupt the interaction between GASP-1 and the beta-2 adrenergic receptor. Finally, preliminary NMR experiments have confirmed the importance of amino acid tryptophan for the interaction with GPCRs and a first crystallization trials were performed with a fragment of GASP -1.